How Much Bacteriostatic Water for PNC-27? (Chart)

Standard Reconstitution Volumes for PNC-27

Determining how much bacteriostatic water to add to a PNC-27 vial depends entirely on the target concentration required for your specific assay protocol, with 1.0 mL to 2.0 mL of 0.9% benzyl alcohol diluent representing the standard range for standard 5 mg or 10 mg lyophilized vials. Reconstituting a 5 mg vial of PNC-27 with 1.0 mL of diluent yields a final concentration of 5.0 mg/mL, whereas adding 2.0 mL yields a concentration of 2.5 mg/mL.

Choosing an appropriate diluent volume balances stock stability, viscosity, and pipette accuracy. Excessively diluted stock solutions require larger pipetting volumes that can alter assay buffer dynamics, while overly concentrated solutions increase the percentage of mass lost to vial dead volume. Researchers preparing high-throughput screen plates often select concentration targets between 1 mg/mL and 5 mg/mL to simplify subsequent serial dilutions.

PNC-27 Reconstitution & Concentration Chart

The following reference matrix details the resulting final concentration (in mg/mL) based on total vial peptide mass and the volume of bacteriostatic water introduced during reconstitution. These calculated values assume full dissolution of the lyophilized cake.

For a 5 mg PNC-27 mass mass profile: Adding 1.0 mL yields 5.00 mg/mL (5.00 mcg/mcL). Adding 2.0 mL yields 2.50 mg/mL (2.50 mcg/mcL). Adding 3.0 mL yields 1.67 mg/mL (1.67 mcg/mcL). Adding 5.0 mL yields 1.00 mg/mL (1.00 mcg/mcL).

For a 10 mg PNC-27 mass mass profile: Adding 1.0 mL yields 10.00 mg/mL (10.00 mcg/mcL). Adding 2.0 mL yields 5.00 mg/mL (5.00 mcg/mcL). Adding 3.0 mL yields 3.33 mg/mL (3.33 mcg/mcL). Adding 5.0 mL yields 2.00 mg/mL (2.00 mcg/mcL).

Researchers can utilize our automated reconstitution calculator to quickly calculate custom concentrations and unit conversions for variable assay parameters across our full catalog of research peptides.

Mathematical Principles of Laboratory Peptide Reconstitution

Calculating peptide concentration relies on the fundamental relationship between mass, volume, and concentration expressed by the equation C = m / V, where C is concentration (mg/mL), m is total peptide mass (mg), and V is total diluent volume (mL). When performing precise biochemical assays, researchers must account for both mass unit conversions and molar mass to calculate micromolar (µM) stock solutions.

PNC-27 has a molecular weight of approximately 3,544.1 g/mol. To calculate the molar concentration (M) of a reconstituted PNC-27 stock, divide the concentration in grams per liter (g/L) by the molecular weight. For example, a 5.0 mg/mL (5.0 g/L) solution of PNC-27 corresponds to a molarity of approximately 1.41 mM (1,410 µM). Having a precise molarity calculation is crucial when performing dose-response curves in cancer cell line cultures.

Step-by-Step Reconstitution Protocol for PNC-27

Reconstituting lyophilized peptides requires strict adherence to aseptic technique inside a certified biosafety cabinet or laminar flow hood to prevent microbial contamination and degradation. Begin by sanitizing the rubber septum of the PNC-27 vial and the bacteriostatic water container with 70% isopropyl alcohol wipes.

Using a sterile syringe, draw the exact pre-calculated volume of bacteriostatic water (0.9% benzyl alcohol preserved). Insert the needle through the center of the rubber stopper at a 45-degree angle, allowing the vacuum within the vial to draw the liquid in gradually. Aim the liquid stream against the inner glass wall of the vial rather than directly onto the lyophilized cake to minimize mechanical shear stress.

Allow the diluent to fully wet the lyophilized material. Gently swirl the vial in a circular motion until the cake is completely dissolved and the solution appears clear and free of particulate matter. Never shake or vortex the vial, as violent agitation causes foaming, structural alteration, and denaturation of the peptide chain.

Grounding Mechanism: Membrane-Active Necrosis via HDM-2 Binding

PNC-27 is a specialized research compound classified as a membrane-active anticancer peptide. Preclinical studies suggest that PNC-27 selectively targets cancer cells by binding to membrane-bound HDM-2 (human double minute 2) protein complexes expressed uniquely on the cell membranes of transformed neoplastic cells, while remaining inactive against non-transformed somatic cells.

Unlike classic p53-pathway activators that depend on nuclear transcription mechanisms, in vitro data indicate that PNC-27 induces rapid cell lysis through transmembrane pore formation. Upon binding to surface HDM-2, the peptide undergoes a conformational alteration that enables its hydrophobic membrane-penetrating domain to insert directly into the lipid bilayer, creating non-specific transmembrane pores that lead to cellular swelling, membrane disruption, and rapid necrosis independent of functional p53 expression.

Comparative Analysis: PNC-27 vs. Related Cytotoxic Research Peptides

In oncology models, researchers frequently evaluate PNC-27 alongside alternative targeted peptide structures and p53-modulating agents. A key sibling molecule is PNC-28, which shares identical p53-derived binding sequence elements (residues 12–26) linked to a similar membrane-penetrating domain, serving as a primary comparator in pore-formation assays. Investigators examining alternative p53-HDM2 interaction disruptors often evaluate small molecules such as Nutlin-3a or peptide analogs like p53-derived peptide constructs, which function via nuclear accumulation and apoptosis rather than direct membrane lysis.

While traditional apoptosis-inducing compounds rely on intact intracellular cascades and active caspase signaling, PNC-27 stands out in comparative literature due to its direct, physical membrane-disruptive mechanism. This distinct mode of action makes it a valuable control and focus area in drug-resistance models where apoptotic machinery (such as p53 mutations) is rendered non-functional.

Handling, Storage, and Aliquoting Guidance for Laboratories

To preserve the structural stability of reconstituted PNC-27, proper storage and aliquoting procedures are mandatory. Repeated freeze-thaw cycles subject peptide molecules to ice-crystal formation and localized concentration spikes, resulting in significant peptide aggregation and loss of functional activity.

Immediately following reconstitution, split the main stock solution into single-use microcentrifuge aliquots using sterile, low-binding microcentrifuge tubes. Store working aliquots at -20°C or -80°C for long-term experimental series. Reconstituted solutions stored at 2°C to 8°C in bacteriostatic water remain stable for limited durations (typically up to 28 days), provided benzyl alcohol antimicrobial preservation is maintained.

Quality Verification & Purity Standards at PX1 Research

Experimental reproducibility depends entirely on peptide purity, sequence fidelity, and chemical consistency. Impurities such as truncated peptides, residual solvents, or heavy metal contamination can invalidate cell culture assays and alter binding kinetics. PX1 Research supplies USA-manufactured research peptides synthesized under stringent quality protocols.

Every production lot undergoes rigorous analytical testing, including High-Performance Liquid Chromatography (HPLC) to verify purity levels equal to or exceeding 98%, and Mass Spectrometry (MS) to confirm exact molecular weight. Furthermore, all lots undergo chromogenic LAL assays to ensure low endotoxin levels suitable for delicate in vitro assays. Researchers can access batch-specific documentation directly via our COA portal or contact our team for wholesale lab accounts.